… antiplatelet agents for patients requiring physician home visit, … of antiplatelet agents might
not generalize to other situation. … of antiplatelet drugs may have beneficial effects on mortality …

… Numbers at risk refer to survivors undergoing follow-up at the start of each year according
to treatment allocation. Plot was censored at 5 years. Cumulative events indicate the …

… -up by a primary care practitioner or those receiving no follow-… perceived to have adverse
consequences, as well as the … intuition, continuity of care is critical because patients without …

… oral antiplatelet therapy at the time of and after DES implantation. It also examines the clinical
impact … on prasugrel at the time of PCI, if indicated by the physician in charge of the patient. …

… physician, they had a life expectancy of less than 1 month, had an indication for anticoagulant
treatment (for … members were instructed how to inject the study treatment, but home care or …

… Effects of clopidogrel in addition to aspirin in patients with … association with survival in real
life health care of patients with ST-… means and adjunctive antithrombotic treatment have been …

… of diagnosis; date of last visit; demographics of patients (sex, race, … None of them were
receiving anticoagulant treatment at the … We had to limit the extension of the survival analysis to 15 …

… every follow-up visit. Medication use was self-reported by the … general practitioner to determine
treatment adherence. Only … in patients taking antiplatelet agents but also in patients not …

… Physicians were instructed that the study should not affect clinical care or management. …
contraindications to specific therapies, particularly antithrombotic therapies to change markedly. …

… disease in the primary care, and patients with PAD are not treated … physician, or if patients
were taking lipid-lowering agents. … the optimal antiplatelet treatment choice in patients with PAD…